ask="0.7200"
ask_size="10000"
average_daily_volume="2365650"
bid="0.6100"
bid_size="3000"
book_value="0.1800"
change="-0.0586"
change_from_200_day_moving_average="-1.2936"
change_from_50_day_moving_average="0.0165"
change_from_52_week_high="-4.2602"
change_From_52_week_low="0.1298"
change_in_percent="-8.3906%"
close="0.6398"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6100"
ebitda="-56.86M"
eps_estimate_current_year="-1.2300"
eps_estimate_next_quarter="-0.2600"
eps_estimate_next_year="-1.0800"
ex_dividend_date="N/A"
float_shares="36794000"
high="0.7194"
high_52_weeks="4.9000"
last_trade_date="3/3/2017"
last_trade_price="0.6398"
last_trade_size="5991"
last_trade_time="4:00pm"
low="0.6350"
low_52_weeks="0.5100"
market_capitalization="26.84M"
moving_average_200_day="1.9334"
moving_average_50_day="0.6233"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.6900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-66.9085%"
percent_change_from_50_day_moving_average="+2.6418%"
percent_change_from_52_week_high="-86.9429%"
percent_change_from_52_week_low="+25.4510%"
previous_close="0.6984"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.8800"
price_per_sales="202.0798"
revenue="144999.00"
shares_outstanding="41955000"
short_ratio="3.7000"
stock_exchange="NGM"
symbol="ANTH"
volume="2171223"
weeks_range_52="0.5100 - 4.9000"
